Abiopharma

🔍 Barmonde Charles L. (Executive)

Company: E.W. SCRIPPS Co (SSP)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 90,673 shares of Class A Common Shares, $.01 par value per share (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: false | shares_owned_after: 830,742.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Shares, $.01 par value per share (Direct)
  Date: 2026-05-04 | Code: H
• Holds 0 shares of Common Voting Shares, $.01 par value per share (Direct)
  Date: 2026-05-04 | Code: H | nature_of_ownership: Revocable Living Trust | shares_owned_after: 585,666.00
• Holds 0 shares of Common Voting Shares, $.01 par value per share (Direct)
  Date: 2026-05-04 | Code: H
• Sold 0 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2026-05-05 | Exercise: 2026-05-05 | equity_swap_involved: false | transaction_form_type: 4
• Acquired 0 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-04 | Code: A | Expires: 2027-05-04 | Exercise: 2027-05-04 | equity_swap_involved: false | shares_owned_after: 49,575.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: This transaction reflects the conversion of restricted stock units into Class A Common Shares.
• F2: This restricted stock unit award will vest in 2027. Upon vesting, each restricted stock unit will convert into one Class A Common Share of the Company.
• REMARKS: The reporting person may be deemed to have shared voting power with respect to more than 10% of the Class A Common Shares of the Issuer (due solely to the convertibility of Common Voting Shares of the Company into Class A Common Shares on a share-for-share basis) due to the voting provisions of the Second Amended and Restated Scripps Family Agreement, dated May 26, 2021, to which the reporting person is a party. The reporting person filed a Schedule 13D with the Commission on January 24, 2013, as last amended on February 21, 2023.